Lumevoq Gene Therapy in Leber Hereditary Optic Neuropathy (LHON):

Time: 2:00 pm
day: Day Two

Details:

  • Exploring the main clinical aspects of LHON, a rare and acute mitochondrial disease
  • Evaluating late-stage development of Lumevoq gene therapy
  • Discussing on regulatory pathways
  • Highlighting key learnings

Speakers: